Alivus Life Sciences

1,087.60
+25.95
(2.44%)
Market Cap
13,327.13 Cr
EPS
38.43
PE Ratio
29.59
Dividend Yield
2.11 %
Industry
Healthcare
52 Week High
1,251.00
52 Week Low
868.10
PB Ratio
5.15
Debt to Equity
0.01
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy+100.00 %
+100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,723.05
#1 4,13,417.41
35.22
#1 49,887.20
12.06
#1 9,648
13.77
54.16
5,776.50
1,53,347.93
75.20
8,184.00
0.89
1,600
#1 64.53
56.90
1,449.75
1,17,083.98
24.00
26,520.70
14.17
4,155
47.38
51.80
3,215.75
1,08,835.59
58.64
10,785.70
11.59
1,656
13.54
59.74
2,421.45
99,903.83
49.78
10,615.60
19.57
1,942
-16.38
59.91
1,146.25
95,649.45
#1 18.06
28,905.40
12.36
5,578
1.69
47.74
2,004.00
91,490.81
32.14
20,141.50
#1 19.94
1,936
38.82
47.45
884.25
88,976.24
19.77
19,831.50
13.82
3,831
29.92
42.86
1,154.75
67,068.07
19.21
29,559.20
17.55
3,169
-10.04
53.81
30,760.75
65,364.45
48.70
6,097.20
10.80
1,201
16.01
55.29
Growth Rate
Revenue Growth
4.80 %
Net Income Growth
0.84 %
Cash Flow Change
35.13 %
ROE
-7.55 %
ROCE
-8.03 %
EBITDA Margin (Avg.)
-2.45 %

Yearly Financial Results

Annual Financials
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
0
887
1,549
1,886
2,138
2,190
2,295
2,302
Expenses
0
639
1,065
1,294
1,507
1,519
1,609
1,648
EBITDA
0
248
484
592
631
671
686
653
Operating Profit %
-5 %
28 %
31 %
31 %
29 %
30 %
30 %
27 %
Depreciation
0
19
29
33
38
42
54
59
Interest
0
1
34
88
28
1
2
2
Profit Before Tax
0
228
421
471
565
629
631
593
Tax
0
33
108
119
146
162
160
146
Net Profit
-0
196
313
352
419
467
471
442
EPS in ₹
-7.89
24.64
29.04
32.61
35.63
38.11
38.43
36.10

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
Total Assets
0
1,475
1,726
1,997
2,471
2,702
2,850
Fixed Assets
0
456
546
573
590
781
805
Current Assets
0
931
1,160
1,399
1,765
1,850
1,916
Capital Work in Progress
0
80
11
14
97
62
106
Investments
0
0
0
0
0
0
0
Other Assets
0
939
1,169
1,410
1,784
1,860
1,939
Total Liabilities
0
1,475
1,726
1,997
2,471
2,702
2,850
Current Liabilities
2
1,380
1,308
1,221
384
497
439
Non Current Liabilities
0
7
16
23
33
67
79
Total Equity
-1
88
402
753
2,054
2,138
2,332
Reserve & Surplus
-1
86
400
751
2,030
2,114
2,308
Share Capital
0
2
2
2
25
25
25

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
2
8
106
397
-228
18
Investing Activities
0
-9
-51
-69
-122
-147
-117
Operating Activities
-1
10
195
388
598
306
414
Financing Activities
1
1
-137
-214
-79
-388
-279

Share Holding

% Holding
Apr 2021
Aug 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
100.00 %
82.84 %
82.84 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
75.00 %
75.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.00 %
0.00 %
0.00 %
4.38 %
0.00 %
5.01 %
4.82 %
7.85 %
6.74 %
DIIs
0.00 %
1.34 %
0.30 %
0.32 %
0.50 %
0.71 %
0.79 %
0.09 %
0.00 %
0.58 %
0.64 %
0.59 %
1.40 %
1.57 %
4.16 %
4.86 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
7.99 %
7.97 %
7.72 %
7.80 %
8.14 %
9.14 %
9.77 %
10.87 %
10.02 %
9.20 %
9.20 %
9.09 %
9.13 %
10.63 %
10.99 %
Others
0.00 %
7.83 %
8.89 %
9.11 %
8.86 %
8.31 %
7.21 %
7.29 %
6.28 %
6.55 %
2.92 %
7.36 %
1.64 %
1.64 %
2.36 %
2.41 %
No of Share Holders
7
3,73,362
2,80,300
2,53,726
2,38,578
2,33,538
2,32,203
2,25,730
2,22,866
2,08,267
1,98,764
1,85,531
1,56,183
1,49,396
1,43,960
1,46,840

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 21 42 22.5 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 5.49 5.41 2.12 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 03, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 27, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 27, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Feb 26, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Feb 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 21, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 31, 2025
Transcript Of Earnings Call.Jan 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 23, 2025
Integrated Filing (Financial)Jan 23, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 23, 2025
Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31 2024Jan 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 17, 2025
Closure of Trading WindowJan 16, 2025
Board Meeting Intimation for Inter Alia To Consider And Approve The Unaudited Financial Results Of The Company For The Third Quarter And Nine Months Ended 31St December 2024Jan 16, 2025
Announcement under Regulation 30 (LODR)-Change of Company NameDec 17, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportNov 27, 2024
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotNov 27, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 25, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 22, 2024
Transcript Of Earning CallOct 31, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 28, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 26, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 25, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 25, 2024
Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 25, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationOct 24, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 24, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 24, 2024
Unaudited Finanacial Results For The Second Quarter And Half Year Ended 30Th September 2024.Oct 24, 2024
Disclosure Pursuant To Regulation 31A Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 As Amended (SEBI Listing Regulations') - Re-Classification From 'Promoter Group' Category To 'Public Category' Of Glenmark Life Sciences Limited ('The Company')Oct 22, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 18, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 18, 2024
Closure of Trading WindowOct 17, 2024
Board Meeting Intimation for Inter Alia, To Consider And Approve The Unaudited Financial Results, Of The Company For The Second Quarter And Half Year Ended 30Th September, 2024.Oct 17, 2024
Announcement under Regulation 30 (LODR)-Change of Company NameOct 09, 2024
Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('SEBI Listing Regulations')Oct 03, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 25, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 16, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 03, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2024
Business Responsibility and Sustainability Reporting (BRSR)Sep 02, 2024
Notice Of 13Th Annual General Meeting Of The Company For FY 2023-24 As Required Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Sep 02, 2024
Reg. 34 (1) Annual Report.Sep 02, 2024

Technical Indicators

RSI(14)
Neutral
51.30
ATR(14)
Volatile
62.10
STOCH(9,6)
Neutral
53.66
STOCH RSI(14)
Neutral
24.55
MACD(12,26)
Bullish
3.26
ADX(14)
Weak Trend
15.81
UO(9)
Bearish
45.58
ROC(12)
Uptrend And Accelerating
2.40
WillR(14)
Neutral
-47.93